about
An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis.The antihypertensive drug hydralazine activates the intrinsic pathway of apoptosis and causes DNA damage in leukemic T cells.Influence of TYK2 in systemic sclerosis susceptibility: a new locus in the IL-12 pathway.A versatile T cell-based assay to assess therapeutic antigen-specific PD-1-targeted approaches.Efficient and Non-genotoxic RNA-Based Engineering of Human T Cells Using Tumor-Specific T Cell Receptors With Minimal TCR MispairingThe role of the common gamma-chain family cytokines in γδ T cell-based anti-cancer immunotherapyDendritic Cell-Based Immunotherapy of Acute Myeloid LeukemiaCellular immunotherapy: a clinical state-of-the-art of a new paradigm for cancer treatmentChimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation AntigenPD-L1 siRNA-mediated silencing in acute myeloid leukemia enhances anti-leukemic T cell reactivity
P50
Q38698316-6F820DA2-A0AB-4F1E-BE87-1F032B80BAACQ40996500-0E01A29C-385F-4516-8E2F-9659A9DB7C9BQ52862671-A36F46DF-EB33-43D1-82DB-7DE335DB864EQ55348052-633E0645-1DA3-4A0E-9DED-59F0CA4F1BEDQ59125585-9353B29C-2766-41A2-8D1C-BB92D0BC1CB1Q88720419-C237B551-5EE0-416B-BE22-539C9A6FDDEDQ91613560-198170D5-B124-47EB-A7EF-15B89C872E91Q91716964-FDEE760F-9574-4296-BE94-C897F561544BQ92404828-6AA8C974-613E-47FD-8343-130DF08CAC14Q96302744-2597A0E7-0499-4B0B-85A9-E37BA2257DC3
P50
description
researcher ORCID ID = 0000-0002-6080-3935
@en
wetenschapper
@nl
name
Diana Campillo-Davó
@ast
Diana Campillo-Davó
@en
Diana Campillo-Davó
@es
Diana Campillo-Davó
@nl
type
label
Diana Campillo-Davó
@ast
Diana Campillo-Davó
@en
Diana Campillo-Davó
@es
Diana Campillo-Davó
@nl
prefLabel
Diana Campillo-Davó
@ast
Diana Campillo-Davó
@en
Diana Campillo-Davó
@es
Diana Campillo-Davó
@nl
P106
P21
P31
P496
0000-0002-6080-3935